These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 4136186)

  • 1. Letter: Cytotoxic lymphocytes from normal donors.
    Kay HD; Sinkovics JG
    Lancet; 1974 Aug; 2(7875):296-7. PubMed ID: 4136186
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytotoxic lymphocytes. II. Antagonism and synergism between serum factors and lymphocytes of patients with sarcomas as tested against cultured tumor cells.
    Sinkovics JG; Ahmed N; Hrgovcic MJ; Cabiness JR; Wilbur JR
    Tex Rep Biol Med; 1972; 30(4):347-60. PubMed ID: 4121149
    [No Abstract]   [Full Text] [Related]  

  • 3. Specificity of in vitro cellular cytotoxicity against transitional cell carcinoma cell line T-24.
    Catalona WJ; Oldham RK; Djeu JY; Herberman RB; Cannon GB
    Surg Forum; 1975; 26():122-4. PubMed ID: 56048
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparative study on in vitro cytotoxic reactions of lymphocytes from normal donors and patients with sarcomas to cultured tumor cells.
    Kay HD; Thota H; Sinkovics JG
    Clin Immunol Immunopathol; 1976 Mar; 5(2):218-34. PubMed ID: 945141
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium.
    Vilien M
    Dan Med Bull; 1985 Aug; 32(4):199-218. PubMed ID: 3899526
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro generation of cytotoxic lymphocytes by tumor extracts of transitional cell carcinoma.
    Morales A
    Natl Cancer Inst Monogr; 1978 Dec; (49):173-4. PubMed ID: 748769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of Fab fragments of anti-human immunoglobulin as analytic tools for establishing the involvement of immunoglobulin in the spontaneous cytotoxicity to cultured tumor cells by lymphocytes from patients with bladder carcinoma and from healthy donors.
    Troye M; Perlmann P; Pape GR; Spiegelberg HL; Näslund I; Gidlöf A
    J Immunol; 1977 Sep; 119(3):1061-7. PubMed ID: 302271
    [No Abstract]   [Full Text] [Related]  

  • 8. Transitional cell and renal carcinoma: cell-mediated immunity as determined by the lymphocyte titration technique.
    Hakala TR
    Natl Cancer Inst Monogr; 1978 Dec; (49):151-2. PubMed ID: 571043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of cytolytic effector cells in peripheral blood of healthy individuals and cancer patients. II. Cytotoxicity to allogeneic or autochthonous tumor cells in tissue culture.
    Pape GR; Troye M; Perlmann P
    J Immunol; 1977 Jun; 118(6):1925-30. PubMed ID: 325130
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of cell-mediated cytolytic mechanisms against human transitional cell carcinoma line, 253J.
    Catalona WJ; Ratliff TL; McCool RE
    Immunology; 1980 Jan; 39(1):119-25. PubMed ID: 7380462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transitional cell carcinoma: lymphocyte-mediated cytotoxicity.
    Troye M; Pape GR
    Natl Cancer Inst Monogr; 1978 Dec; (49):85-7. PubMed ID: 311895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The concept of immunotherapy of human sarcomas: the need for an in vitro monitoring assay.
    Sinkovics JG; Campos LT; Kay HD; Loh KK; Cabiness JR; Ervin F
    Ann Clin Lab Sci; 1973; 3(6):414-23. PubMed ID: 4796444
    [No Abstract]   [Full Text] [Related]  

  • 13. Suppressive effect of prednisolone on cytotoxicity of lymphocytes from normal persons against T24 cells.
    Nemoto R; Kato T
    Gan; 1979 Feb; 70(1):95-100. PubMed ID: 446979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro studies of cell mediated immunity to human sarcomas.
    Rella W; Kotz R; Vetterlein M
    Osterr Z Onkol; 1974; (3-4):89-96. PubMed ID: 4143396
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytotoxic lymphocytes from normal donors. A functional marker of human non-T lymphocytes.
    Pross HF; Jondal M
    Clin Exp Immunol; 1975 Aug; 21(2):226-35. PubMed ID: 810282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody induction of lymphocyte-mediated cytotoxicity against human transitional-cell carcinomas of the urinary tract.
    Hakala TR; Lange PH; Castro AE; Elliott AY; Fraley EE
    N Engl J Med; 1974 Sep; 291(13):637-41. PubMed ID: 4859212
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro sensitization of human lymphocytes against histiocytic lymphoma cell lines. I. Primary sensitization of lymphocyte subpopulations.
    Treves AJ; Feldman M; Kaplan HS
    J Immunol; 1977 Sep; 119(3):955-60. PubMed ID: 70479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of primary tumor bed lymphocytic infiltration and peripheral lymphocyte cytotoxicity in patients with transitional cell carcinoma.
    Jones LW; O'Toole C
    Natl Cancer Inst Monogr; 1978 Dec; (49):183-5. PubMed ID: 748770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human lymphoma cell-line colony formation by lymphocytes from patients with lymphoma and cancer hospital employees.
    Drewinko B; Mavligit GM; Ambus U; Hersh EM
    Cancer; 1976 Jun; 37(6):2929-37. PubMed ID: 779948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructure, karyology and immunology of a cell line originated from a human transitional-cell carcinoma.
    O'Toole C; Price ZH; Ohnuki Y; Unsgaard B
    Br J Cancer; 1978 Jul; 38(1):64-76. PubMed ID: 687519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.